SpaceX (SPCX) is changing hands well below the price at which it debuted publicly and is trading essentially at the bottom of its range since the IPO. The stock is 14.6% under the $135 IPO price and is near its 52-week low of $115.19, with a one-month loss of 26.2% and a nearly 49% decline from its post-IPO high of $225.64.
Market snapshot heading into the trading day shows SPCX at $115.26 (pre-market $115.96), with a 52-week range of $115.19 to $225.64. The company carries a market capitalization of $1.52 trillion, reported Q1 2026 EPS of -$1.19, and Q1 revenue of $4.69 billion. These figures frame the debate: the share price has corrected materially, but a structural supply event arriving in short order represents the dominant near-term uncertainty for the stock.
The supply shock: A lockup expiry scheduled to take effect on the second trading day after SpaceX’s Q2 report on August 4 will make 911.5 million shares freely sellable. At the $135 IPO price, that amount equates to roughly $123 billion of potential supply. This is not a typical, modest lockup release; it represents a sudden and substantial increase in available stock, and the size of the tranche relative to overall market capitalization gives it outsized potential impact on price discovery.
A secondary tranche of 455.8 million shares is structured to unlock only if SPCX trades above $175.50 for 5 of 10 consecutive trading days. Given current levels and the near-term supply event, that contingency appears distant.
Short interest amplifies the caution. SPCX ranks as the ninth most-shorted U.S. equity, with approximately $25 billion in short positions, representing about 29% of the float. Those short positions have delivered roughly 28% in mark-to-market profits this year, reinforcing a market structure that can accelerate downward moves if selling pressures materialize.
Bull case - catalysts proponents point to:
- Revenue growth that appears real on current estimates, with annual revenue projections up about 24.6% year-over-year.
- Operational expansion in AI infrastructure: SpaceXAI is pursuing a large-scale data center initiative in Texas tied to the xAI and Starlink ecosystem, a move cited as evidence of accelerating commercial scale in compute and connectivity.
- Analyst commentary that emphasizes optionality from AI-related initiatives, with Macquarie analysts noting that realizing even a fraction of terminal compute ambitions could justify valuations materially above current levels.
The analyst target universe is varied and skewed to the upside in places. Representative targets include an outperform stance with a $239 price target indicated by one firm and a $156 target from another, implying substantial upside from current levels at the higher end of the range. InvestingPro’s fair value estimate stands at $111.37, which implies the stock is modestly below fair value on that particular metric.
Bear case - valuation and execution risks:
- SpaceX remains unprofitable on an EPS basis. Q1 2026 reported EPS was -$1.19, and there is no consolidated consensus estimate available yet for Q2.
- Analyst EPS revisions have moved sharply lower recently, with a 46.2% collapse in EPS revisions over the last 30 days, signaling rapidly deteriorating near-term expectations among sell-side analysts.
- At a market capitalization of $1.52 trillion for a money-losing company, the valuation assumes near-perfect execution going forward, leaving little margin for missed targets.
- The impending lockup release is mathematically unforgiving: even modest selling by pre-IPO stakeholders - including employees, early investors, or major shareholders - could swamp organic demand around current price levels.
The August 4 inflection point: SpaceX will release Q2 2026 earnings and host a webcast on August 4 at 4:30 PM ET. That filing starts the clock on the lockup expiry mechanics. Practically, the market has positioned itself for a ‘‘show me’’ moment: can the company demonstrate a credible path to profitability and absorb the waves of supply tied to pre-IPO holdings?
Complicating the narrative, merger speculation represents an asymmetric wildcard. Elon Musk declined to categorically rule out a combination between Tesla and SpaceX on Tesla’s July 22 earnings call, and commentary from market participants has put a high subjective probability on an eventual consolidation. Such discussion can add episodic upside narratives but does not change the immediate structural supply dynamics headed into August.
Bottom line: The recent decline in SPCX shares is real and underpinned by observable trading and fundamental metrics. Equally real is the structural overhang represented by the 911.5 million-share lockup expiry, which could substantially alter the stock’s floor by introducing a very large block of shares into the market in a compressed time frame. Historically, buying into large, imminent lockup expiries has been a low-probability strategy, and the risk-reward equation will likely change materially once the August supply dynamics are resolved. The broad dispersion in analyst targets reflects genuine uncertainty about execution and valuation outcomes rather than uniform bullish conviction.